MICHELLE ROGERS: Open Payments
NPI 1346485612 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$252 in 12 payments from 6 companies in 2025. Trend: 2023 $346 · 2024 $303 · 2025 $252
Food & beverage: $252
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $62 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Merck Sharp & Dohme LLC | 2 | $47 |
| Eisai Inc. | 2 | $46 |
| Genmab U.S., Inc. | 1 | $28 |
| ABBVIE INC. | 1 | $18 |
Products named: JEMPERLI, LYNPARZA, KEYTRUDA, Lenvima, ELAHERE.
Industry payments across NY — which companies pay providers there.
